Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

EQT AB resolves on repurchase of own ordinary shares

The Board of EQT AB (“EQT”) has resolved to repurchase a maximum of 2,154,000 own ordinary shares for a total maximum amount of SEK 1,000,000,000. The resolution is made by virtue of the authorization granted by the Annual Shareholders’ Meeting held on 30 May 2023 to repurchase own shares.· As previously communicated, EQT expects to execute share buyback programs twice a year to offset - over time - the dilution impact from shares delivered to EQT’s employees under its Share and Option incentive programs. · Pursuant to the upcoming repurchase program, a maximum of 2,154,000 ordinary

Repurchases of shares in Hoist Finance during week 16, 2024

During the period 15 April 2024 – 19 April 2024 Hoist Finance AB (publ) (LEI code: 549300NPK3FB2BEL4D08) (”Hoist Finance”) has repurchased in total 185,000 own shares (ISIN: SE0006887063), as part of the repurchase programme initiated by the Board of Directors. The repurchases form part of the repurchase programme of a maximum of 10 percent of the total number of shares in the company for a total amount of not more than SEK 100,000,000 that Hoist Finance announced on 6 February 2024. The repurchase programme runs during the period from and including 8 February 2024 until the Annual

Buy-back of shares in Arise during week 16, 2024

During the period between 15 April and 19 April 2024 Arise AB (publ) (LEI code 549300FOT7EE85QYB655) (“Arise”) repurchased, in total, 77,372 own shares (ISIN code SE0002095604) under the share repurchase program initiated by the Board of Directors to deliver shareholder value and to optimize the capital structure of the company. The share buy-backs form a part of the share repurchase program of a maximum amount of SEK 100 million, which Arise announced on 14 November 2023. The share repurchase program, which runs from 16 November 2023 until the date of Arise's Annual General Meeting in

Pihlajalinna Oyj: Acquisition of own shares on April 22, 2024

Pihlajalinna Oyj: Acquisition of own shares on April 22, 2024 Pihlajalinna Oyj’s stock exchange release on April 22, 2024, at 07:00 p.m. EET Date April 22, 2024Exchange transaction BuyShare trading code PIHLISAmount, shares 1,581Average price/share (EUR) 7.7825Total cost (EUR) 12,304.13 After the acquisitions Pihlajalinna Oyj holds a total of 77,350 treasury shares. ON BEHALF OF PIHLAJALINNA OYJ Danske Bank A/S, Finland Branch  Antti Väliaho                        Jonathan Nyberg Additional

Supporting Nigerian farmers by transforming food waste into valuable material

Academics from Teesside University are collaborating with counterparts in Nigeria on a groundbreaking project to turn food waste into a valuable material used to restore the environment and remove carbon dioxide from the atmosphere. The University is teaming up the University of Ibadan and Niji group, a Nigerian agricultural company, to deliver an African Agricultural Knowledge Transfer Partnership (AA KTP) project, looking at how waste from the cassava plant can be used to produce biochar. Biochar is a charcoal-like product which has multiple useful properties including

Resolutions at Getinge’s Annual General Meeting 22 April 2024

Getinge AB (publ)’s Annual General Meeting (“AGM”) was held on 22 April 2024 in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. At the AGM, the following was resolved.Adoption of the Income Statement and the Balance Sheet The AGM adopted the Income Statement and the Balance Sheet as well as the Consolidated Income Statement and the Consolidated Balance Sheet for the financial year 2023. Dividend In accordance with the proposal by the Board of Directors and the CEO, the AGM resolved to declare a dividend of SEK 4.40 per share. Wednesday 24 April 2024 was determined as record date

#24-143 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Capsol Technologies ASA – Q1 2024: Accelerating demand growth, expanding offering and reach

Oslo, Norway – April 22, 2024Capsol Technologies ASA, a provider of carbon capture technology to largeemitters, today announced its results for the first quarter of 2024.Accelerating revenues and pipeline growth• Mature stage of sales pipeline totalling 13 million tons of CO2, up 400%year-over-year, with a record number of engineering studies awarded withinenergy-from-waste and cement• Revenues of NOK 19.5 million, compared to NOK 0.9 million in Q1 2023, drivenby engineering studies and CapsolGo® carbon capture demonstration campaigns• Current business plan fully funded

NOBA HOLDING AB (PUBL)’S INDIRECT SUBSIDIARY NOBA BANK GROUP AB (PUBL) RECEIVES AFFIRMED INVESTMENT GRADE RATING FROM NORDIC CREDIT RATING (BBB, STABLE OUTLOOK)

NOBA Bank Group AB (publ) has received an affirmed investment grade rating from the rating institute Nordic Credit Rating with the rating BBB, stable outlook. For the full report, please visit Nordic Credit Rating: https://nordiccreditrating.com/article/noba-bank-group-ab-publ-bbb-long-term-issuer-rating-affirmed-outlook-stable-0 

Saga Pure: Financial update

(Oslo, 22 April 2024) The Board of Directors of Saga Pure ASA (Saga Pure, OSE: SAGA) has today concluded on an impairment of the Company's investment in Heimdall Power AS in the amount of MNOK 37.8. The impairment will be included as part of the result for 2023 in the Annual Report for 2023. The Annual Report will be released before opening of markets on 23 April 2024, and will contain further information with regards to the impairment. The impairment will decrease the Group's equity with MNOK 37,8 compared to numbers as reported in the Company's Q4 2023 Financial Report published on 15

US Among Top Buyers as Global Interest Surges for Eurovision in Sweden 2024

With the Eurovision Song Contest 2024  (ESC) fast approaching, people from all over the globe are flocking to Sweden for this music extravaganza from May 4th-11th. Malmö is gearing up for a global celebration, bringing togther music lovers from across the world with interest in the event extending far beyond the borders of Europe.The US, Germany, Denmark, and the UK are leading in foreign ticket sales 

Bulletin from the AGM of Troax Group AB (publ)

Hillerstorp April 22[nd], 2024 16:30 CETThe AGM of Troax Group AB (publ) was held on April 22[nd], 2024 in Hillerstorp. Adoption of the Income Statements and Balance Sheets, dividend and discharge of liability The Income Statements and Balance Sheets were adopted, together with the Board of Directors` proposal for dealing with the Company ́s profit. The dividend was set at 0,34 Euro per share with April 24[th] as the record day. The estimated date for payment is May 2[nd]. The Board of Directors and the President were discharged from liability for the financial year 2023. . Board

Invitation to presentation of Bravida’s report for the first quarter 2024

Bravida’s report for the first quarter 2024 will be published 12:00 CET on 7 May 2024.The report will be presented at 13:00 CET by CEO and Group President Mattias Johansson and CFO Åsa Neving. The presentation will be held in English and can be followed on the web or by phone. There will be room for questions in the telephone conference. Link to webcast https://ir.financialhearings.com/bravida-q1-report-2024 Telephone conference Register via the link to participate in the telephone conference: https://conference.financialhearings.com/teleconference/?id=5002662. After registration,

Chiquita Showcases The Chiquita Difference Through a Tropical Experience at CPMA 2024

Leading banana brand sees significant growth across Canada, reinforces commitment to sustainabilityFort Lauderdale, FL – April 22, 2024 – Chiquita Brands International  is delighted to announce its return to the Canadian Produce Marketing Association (CPMA)  Annual Convention and Trade Show. Chiquita is set to highlight the Chiquita Difference through its vibrant presence within the Canadian market which is experiencing significant growth coast to coast. Just in time for Earth Month, Chiquita plans to connect with industry leaders, valued

Mellozzan[® ](melatonin) launched in Germany and Austria

EQL's key product Mellozzan[®] has now been launched in Germany and Austria, where it is provided to patients by EQL's license partner Medice Arzneimittel Pütter GmbH & Co. KG. In addition to Germany and Austria, Medice also has ongoing work with registrations in Finland and Switzerland and launch in the UK. In 2023, Medice launched Mellozzan[®] in Denmark and Norway.In parallel with the launch, work is ongoing to get Mellozzan[®] reimbursed in Germany, Austria and the UK. Until that happens, patients will have to pay for the medicine out of pocket which will limit sales initially. This is

The Economy Museum reopens with the permanent exhibition MONEY!

On 1 June, the Economy Museum – The Royal Coin Cabinet opens two exhibitions about money and economy, throughout history and today.“At last, everyone can see our fantastic collections and take a voyage of discovery through the exciting world of money,” says Museum Director Cecilia von Heijne.[New permanent exhibition at the Economy Museum Opened June 1 2024] The Economy Museum opens the first permanent exhibitions at Narvavägen in Stockholm, in the same building as the Swedish History Museum, where it moved a few years ago. Visitors to the exhibition MONEY! can wander through Sweden’

Notice to Annual General Meeting in STENOCARE A/S

STENOCARE A/SNASDAQ FIRST NORHT GROWTH MARKET, DENMARKTICKER: STENOThe board of directors hereby convenes the shareholders of STENOCARE to the Annual General Meeting, which will be held: STENOCARE A/S 14 May 2024 at 3:00 PM (CEST) (the doors open at 2:30 PM)                                   at Lund Elmer Sandager Law Firm Kalvebod Brygge 39-41 DK-1560 København V With the following agenda: 1. Appointment of a chairman of the meeting 2. Report of the chairman of the board of directors 3. Presentation of the annual report together with a resolution for its

The Swedish Sea Rescue Society (SSRS) orders another RescueRunner

SSRS further expands their large fleet of RescueRunners.The Swedish Sea Rescue Society is further expanding its RescueRunner fleet ahead of the 2024 season. SSRS once developed the RescueRunner with the aim of being able to carry out rescue operations in shallow and inaccessible areas where other boats cannot reach. SSRS is not only a customer of Safe at Sea, they are also an important partner who contributes to development and training. "It feels great that we get to continue helping the Swedish Sea Rescue Society with our good business cooperation. We at Safe at Sea hope that this

CS MEDICA Advances Global Reach with 180˚ Drug Store Alliance, Powered by Pull Market Strategy.

Strategic Alliance Catalyzes Market Penetration with a Potential of 440,000 Units in the First Year.CS MEDICA A/S, a first mover in integrating CBD into registered substance-based medical devices, announces a strategic partnership with 180˚ Drug Store to penetrate Germany and key markets in the Gulf Cooperation Council (GCC). This initiative is a cornerstone of CS MEDICA's pull strategy, drawing on the demand for its innovative treatments in pain management, autoimmune and stress-related disorders. Pioneering Innovation and Strategic Market Expansion In the last two years, CS MEDICA

There are no items matching the current filter
There are no more items matching the current filter
Back to top